AstraZeneca PLC Cash Flow Conversion Efficiency

Latest as of June 2026: 0.057x

AstraZeneca PLC cash flow conversion efficiency. Based on the latest financial reports, AstraZeneca PLC (AZN) has a cash flow conversion efficiency ratio of 0.057x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX2.91 Billion ≈ $353.53K USD) by net assets (GBX50.63 Billion ≈ $6.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of AstraZeneca PLC (1990–2025)

Cash flow conversion efficiency of AstraZeneca PLC from 1990 to 2025. This chart illustrates how AstraZeneca PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of AstraZeneca PLC for real-time trading data and today's change.

AstraZeneca PLC Cash Flow Conversion Ratio Explained

AstraZeneca PLC cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

AstraZeneca PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AstraZeneca PLC ranked by their cash flow conversion efficiency. Also see AstraZeneca PLC market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
CLARIANT ADR 1/SF 4 F:CLRS	N/A
Ansell Limited F:PD1A	0.031x
Almirall S.A. MC:ALM	0.060x
Beijing Sinnet Technology Co Ltd SHE:300383	0.033x
ZIM Integrated Shipping Services Ltd. F:2SV	0.093x
NBT Bancorp Inc NASDAQ:NBTB	0.032x
Flat Glass Group Co. Ltd SHG:601865	0.039x
People.Cn Co Ltd SHG:603000	0.020x

Annual Cash Flow Conversion Efficiency for AstraZeneca PLC (1990–2025)

The table below shows the annual cash flow conversion efficiency of AstraZeneca PLC from 1990 to 2025. Review cash generation quality of AstraZeneca PLC to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	GBX48.72 Billion ≈ $5.93 Million	GBX14.57 Billion ≈ $1.77 Million	0.299x	+3.09%
2024-12-31	GBX40.87 Billion ≈ $4.97 Million	GBX11.86 Billion ≈ $1.44 Million	0.290x	+9.87%
2023-12-31	GBX39.17 Billion ≈ $4.77 Million	GBX10.35 Billion ≈ $1.26 Million	0.264x	-0.20%
2022-12-31	GBX37.06 Billion ≈ $4.51 Million	GBX9.81 Billion ≈ $1.19 Million	0.265x	+74.37%
2021-12-31	GBX39.29 Billion ≈ $4.78 Million	GBX5.96 Billion ≈ $725.52K	0.152x	-50.54%
2020-12-31	GBX15.64 Billion ≈ $1.90 Million	GBX4.80 Billion ≈ $583.90K	0.307x	+50.87%
2019-12-31	GBX14.60 Billion ≈ $1.78 Million	GBX2.97 Billion ≈ $361.24K	0.203x	+9.12%
2018-12-31	GBX14.04 Billion ≈ $1.71 Million	GBX2.62 Billion ≈ $318.53K	0.186x	-13.30%
2017-12-31	GBX16.64 Billion ≈ $2.02 Million	GBX3.58 Billion ≈ $435.34K	0.215x	-13.54%
2016-12-31	GBX16.67 Billion ≈ $2.03 Million	GBX4.14 Billion ≈ $504.33K	0.249x	+37.96%
2015-12-31	GBX18.44 Billion ≈ $2.24 Million	GBX3.32 Billion ≈ $404.43K	0.180x	-49.83%
2014-12-31	GBX19.65 Billion ≈ $2.39 Million	GBX7.06 Billion ≈ $858.75K	0.359x	+12.89%
2013-12-31	GBX23.25 Billion ≈ $2.83 Million	GBX7.40 Billion ≈ $900.37K	0.318x	+9.71%
2012-12-31	GBX23.95 Billion ≈ $2.91 Million	GBX6.95 Billion ≈ $845.37K	0.290x	-12.94%
2011-12-31	GBX23.47 Billion ≈ $2.86 Million	GBX7.82 Billion ≈ $951.59K	0.333x	-26.96%
2010-12-31	GBX23.41 Billion ≈ $2.85 Million	GBX10.68 Billion ≈ $1.30 Million	0.456x	-19.08%
2009-12-31	GBX20.82 Billion ≈ $2.53 Million	GBX11.74 Billion ≈ $1.43 Million	0.564x	+3.58%
2008-12-31	GBX16.06 Billion ≈ $1.95 Million	GBX8.74 Billion ≈ $1.06 Million	0.544x	+8.11%
2007-12-31	GBX14.91 Billion ≈ $1.81 Million	GBX7.51 Billion ≈ $913.75K	0.504x	+0.90%
2006-12-31	GBX15.42 Billion ≈ $1.88 Million	GBX7.69 Billion ≈ $936.02K	0.499x	+1.32%
2005-12-31	GBX13.69 Billion ≈ $1.67 Million	GBX6.74 Billion ≈ $820.43K	0.493x	+46.52%
2004-12-31	GBX14.50 Billion ≈ $1.76 Million	GBX4.87 Billion ≈ $592.90K	0.336x	+30.45%
2003-12-31	GBX13.26 Billion ≈ $1.61 Million	GBX3.42 Billion ≈ $415.63K	0.258x	-40.17%
2002-12-31	GBX11.22 Billion ≈ $1.37 Million	GBX4.83 Billion ≈ $588.04K	0.431x	+53.24%
2001-12-31	GBX9.63 Billion ≈ $1.17 Million	GBX2.71 Billion ≈ $329.30K	0.281x	+14.89%
2000-12-31	GBX9.55 Billion ≈ $1.16 Million	GBX2.34 Billion ≈ $284.22K	0.245x	+178.60%
1999-12-31	GBX10.35 Billion ≈ $1.26 Million	GBX908.55 Million ≈ $110.54K	0.088x	+9.62%
1998-12-31	GBX10.98 Billion ≈ $1.34 Million	GBX879.74 Million ≈ $107.04K	0.080x	-61.15%
1997-12-31	GBX3.62 Billion ≈ $440.89K	GBX747.21 Million ≈ $90.91K	0.206x	-4.16%
1996-12-31	GBX3.66 Billion ≈ $445.48K	GBX787.75 Million ≈ $95.85K	0.215x	+11.55%
1995-12-31	GBX3.04 Billion ≈ $369.44K	GBX585.64 Million ≈ $71.25K	0.193x	-15.95%
1994-12-31	GBX2.73 Billion ≈ $331.56K	GBX625.36 Million ≈ $76.09K	0.229x	-24.42%
1993-12-31	GBX2.32 Billion ≈ $282.74K	GBX705.58 Million ≈ $85.85K	0.304x	-75.00%
1992-12-31	GBX169.87 Million ≈ $20.67K	GBX206.27 Million ≈ $25.10K	1.214x	+120.37%
1991-12-31	GBX916.88 Million ≈ $111.56K	GBX505.22 Million ≈ $61.47K	0.551x	-53.33%
1990-12-31	GBX682.84 Million ≈ $83.08K	GBX806.30 Million ≈ $98.10K	1.181x	--

About AstraZeneca PLC

LSE:AZN UK Drug Manufacturers - General

Market Cap

$2.63 Billion

GBX21.60 Trillion GBX

Market Cap Rank

#5119 Global

#13 in UK

Share Price

GBX13930.00

Change (1 day)

-0.80%

52-Week Range

GBX11460.00 - GBX15542.00

All Time High

GBX15542.00